Inscripta (formerly known as Muse Biotechnology) was founded in 2015 by Andrew Garst, Ryan Gill, and Tanya Lipscomb. Following a 2021 funding round, a company spokesperson told reporters that Inscripta has no plans to go public in the near future.

Inscripta is the developer of a genomic engineering platform. Genomic engineering, more commonly known as "gene editing," is the process by which scientists can modify the genetic blueprint of a living organism. Researchers have used the process to modify yeast cells so that the organisms will produce useful byproducts such as fuel, or chemicals with medicinal applications. Inscripta has raised more than $400 million in venture capital funding from investors such as Fidelity Management, T. Rowe Price, and D1 Capital Partners. A company spokesperson declined to offer valuation figures following the 2021 funding round.

These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO.

Register for Details

For more details on financing and valuation for Inscripta, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Inscripta

To invest in Inscripta pre-IPO

Can you invest in Inscripta pre-IPO?

Inscripta is a privately held company and is not publicly traded, therefore investing in Inscripta pre-IPO is only available to accredited investors. If you meet the accreditation criteria, you can learn more about Forge’s Secondary Marketplace and how to invest in private companies before their potential IPO. If you are not accredited, find out how to begin the process and qualify for new investment opportunities.

Can you sell shares of Inscripta before it goes public?

You can seek to sell your shares in Inscripta while it remains private. If you are considering selling, you can register today for free to get started. Once registered, a Private Market Specialist will guide you through any questions you might have. You may also continue to browse through our resources to help you understand the implications and procedures involved in selling your private market shares.

What is the pre-IPO value of my Inscripta shares?

To determine the value of your Inscripta shares, create a free account to gain access to Forge’s platform. In addition to the Forge Price, Forge Markets contains pricing information for hundreds of pre-IPO companies such as Last Closed Trade Price. A Private Market Specialist will also be available to assist you with any inquiries related to your Inscripta shares. You can also learn more about how to sell your private shares before getting started.

Is Inscripta a publicly traded company?

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

To learn more about Inscripta potential IPO

Will Inscripta go IPO?

Inscripta has not yet filed for an IPO. However, it’s important to note that IPOs are not the sole avenue for a private company to transition to public trading. Private companies can also go public through alternative methods such as but limited to Special Purpose Acquisition Companies (SPACs), direct listings, or mergers and acquisitions. Find out which companies are eyeing an IPO on our Tech IPO Calendar 2024.

What is Inscripta’s IPO price?

The Inscripta IPO price does not exist at this time, as Inscripta is still a private company and has not yet conducted an IPO. To explore secondary market data and access private market pricing details and data that may be related to Inscripta register for Forge Markets, today.

When was Inscripta founded?

Inscripta was founded in 2015.

What is Inscripta funding to date?

Inscripta has raised $459.69MM to date.

Who are Inscripta’s major investors?

Venrock
D1 Capital Partners
Durable Capital Partners
Paladin Capital Group
Foresite Capital

Inscripta Funding Rounds and Valuation

Funding History Chart
Funding Round Details
Funding Date Share Class Amount Raised Price per Share Post-Money Valuation Key Investors
04/05/2021 Series E $150MM $xx.xx $1.32B Fidelity, T. Rowe Price
Price per Share
$xx.xx
Shares Outstanding
16,987,539
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Fidelity, T. Rowe Price
11/13/2020 Series D $175MM $xx.xx $594.94MM Venrock, Foresite, Paladin Capital, Mrieux Dveloppement, NanoDimension, MLS Capital, JS Capital Management LLC, Oak HC/FT
Price per Share
$xx.xx
Shares Outstanding
38,293,202
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Venrock, Foresite, Paladin Capital, Mrieux Dveloppement, NanoDimension, MLS Capital, JS Capital Management LLC, Oak HC/FT
04/19/2019 Series C-1 $50MM $xx.xx $278.92MM Venrock, Foresite, Mrieux Dveloppement, Paladin Capital, MLS Capital, NanoDimension
Price per Share
$xx.xx
Shares Outstanding
15,197,562
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Venrock, Foresite, Mrieux Dveloppement, Paladin Capital, MLS Capital, NanoDimension
02/28/2018 Series C $55.5MM $xx.xx $182.26MM Mrieux Dveloppement, Paladin Capital
Price per Share
$xx.xx
Shares Outstanding
19,204,143
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Mrieux Dveloppement, Paladin Capital
02/28/2017 Series B $23.15MM $xx.xx $48.64MM Venrock, Foresite Capital, Paladin Capital, NanoDimension, Spruce/?MLS
Price per Share
$xx.xx
Shares Outstanding
19,784,629
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Venrock, Foresite Capital, Paladin Capital, NanoDimension, Spruce/?MLS
05/30/2016 Series A $6.04MM $xx.xx $13.41MM NanoDimension, Spruce/MLS
Price per Share
$xx.xx
Shares Outstanding
5,157,970
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
NanoDimension, Spruce/MLS
Updated on: Nov 17, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.